A 57-year-old Sinhalese woman presented to the dermatology unit of the National Hospital of Sri Lanka with extensive seborrheic dermatitis and tender facial induration (Fig. ) of 1-year duration. She was a homemaker from an urban area with poor social background. She did not have diabetes or hypertension. She had received a Bacillus Calmette–Guérin (BCG) vaccination. She did not smoke tobacco or drink alcohol. A skin biopsy taken from indurated facial plaque revealed evidence of borderline tuberculoid leprosy with type 1 reaction. She did not have hypopigmented anesthetic patches or thickened peripheral nerves in the rest of her body. She was commenced on multibacillary treatment for leprosy. A year later, she developed fever, loss of appetite, loss of weight, and widespread skin abscesses all over her body. Her body mass index (BMI) was within normal range and the rest of the general examination was normal. A respiratory examination revealed bilateral (B/L) coarse crepitations; a neurological examination was normal. Her erythrocyte sedimentation rate (ESR) remained persistently elevated at more than 120 mm/hour. She had inflammatory shadows in a chest X-ray (CXR). A sputum examination for AFB was positive and GeneXpert confirmed rifampicin resistance. At that time, she revealed a diagnosis of human immunodeficiency virus (HIV) infection and tuberculous lymphadenitis, which was made 5 years back, where she had taken 6-month TB treatment but had defaulted on antiretroviral therapy. During this presentation, her CD4+ count was 57/μL. The rest of the investigations are summarized in Table . There was no contact history of leprosy or TB. She was started on a multidrug treatment regime, which included intravenously administered kanamycin (15 mg/kg per day), orally administered ethambutol (800 mg/day), orally administered levofloxacin (750 mg/day), isoniazid (300 mg/day), orally administered ethionamide (500 mg/day), orally administered cycloserine (750 mg/day), and orally administered pyridoxine (10 mg/day). A repeated split skin smear was negative and she continued with multidrug treatment-multibacillary therapy (dapsone 100 mg/day and clofazimine 50 mg/day and 300 mg/once a month) for leprosy without rifampicin. Highly active antiretroviral treatment was restarted subsequently. At 6 months she had clinically, hematologically, and radiologically improved.
A 29-year-old male, born to nonconsanguineous parents, presented with multiple skin coloured nodules and hyperkeratotic scaly lesions of 3-month duration. He initially developed asymptomatic skin coloured raised lesions over both the ear lobes. Over the next 2 months he developed multiple similar lesions over the trunk and both the extremities. He also gave history of generalised burning sensation for 15-day duration with low grade fever. There was no history of burning sensation in the eyes, nasal stuffiness, and sensory or motor weakness. The patient denied any drug intake, fever, myalgia, spontaneous blistering or ulceration, neuritic pain, and testicular pain. None of the family members or neighbours had suffered from leprosy. He denied any past history of infectious diseases but there was no history of immunization including Bacillus Calmette et Guérin (BCG) vaccination. He was a chronic alcoholic.\nHis general physical examination was normal with no madarosis or lymphadenopathy. Cutaneous examination revealed multiple, soft, succulent, nontender, skin coloured superficial nodules present bilaterally on the forehead, cheeks, ear lobes, forearms, back, and chest with sparing of palms and soles (). The surface of these nodules showed follicular plugging. Multiple verrucous plaques were seen over the right ankle (). Skin surrounding the plaques was erythematous. Neurological examination revealed thickened bilateral greater auricular, right common peroneal nerve, and tender left posterior tibial nerve. The rest of the musculoskeletal and neurological examination was normal. Routine haematological and biochemical investigations including urine, renal, and liver function test revealed no abnormality. His retroviral serology was negative. Chest X-ray was normal. Slit skin smear from the lesion showed a bacteriological index (BI) of 5+ and the perilesional skin had a BI of 2+.\nHistopathological examination of the wedge biopsy done from the forearm and back nodules revealed sheets of histiocytes aggregates along with lymphocytes and few polymorphs in perivascular and periadnexal location (Figures and ). There was collection of epithelioid cells (). Fite Faraco stain was strongly positive (). A diagnosis of borderline lepromatous leprosy with type 2 reaction was made.\nA wedge biopsy from the verrucous lesion on the right ankle was taken. Epidermis showed hyperkeratosis and parakeratosis with irregular acanthosis (). Dermis showed epithelioid cell granulomas along with lymphocytes and plasma cells (Figures and ). Zeihl-Neelsen stain for acid fast bacilli was positive (). GeneXpert MTB/RIF test based on Nucleic Acid Amplification, which detects MTB-specific region of the rpoB gene and uses real time-PCR (RT-PCR), was done on skin biopsy specimen. The result was positive. However, a culture was not done. Based on clinical and histopathological findings, a diagnosis of tuberculosis verrucosa cutis (TVC) was made.\nThe patient was treated with rifampicin, isoniazid, pyrazinamide, and ethambutol, in addition to dapsone and clofazimine along with a monthly supervised dose of clofazimine and rifampicin for first 2 months. Then rifampicin and isoniazid with dapsone and clofazimine were continued for further 4 months. After 6 months, treatment of leprosy was continued as for multibacillary leprosy. Type 2 reaction was treated with oral anti-inflammatory drugs. The patient tolerated the drugs well with control of type 2 reaction and regression of the TVC lesion.